Analyst Ratings for Infinity Pharmaceutical (INFI) [Neutrals]
INFI Rating Summary
INFI Price Target Summary
- Highest: $50.00 (Piper Jaffray)
- Lowest: $12.00 (ThinkEquity)
- Average: $39.22
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$39.22 (+111.1%)
Avg. $ Target:
$39.22 (+111.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Goldman Sachs | New Coverage | Neutral (N/A) |
42.00 (N/A) |
37.44 | 18.58 | -50.37% | Details |
| 4/2/2013 | JMP Securities | New Coverage | Market Perform (N/A) |
N/A (N/A) |
49.53 | 18.58 | -62.49% | Details |
| 11/7/2012 | Jefferies » Updated 3/6/2013 |
Downgrade | Hold (Buy) |
41.00 (21.00) |
20.20 | 18.58 | -8.02% | Details |
| 1/5/2012 | Rodman & Renshaw | New Coverage | Market Perform (N/A) |
N/A (N/A) |
8.31 | 18.58 | 123.59% | Details |
